These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8733166)

  • 21. DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disorders.
    Johnson WG
    Am J Med Genet; 1999 Aug; 88(4):311-23. PubMed ID: 10402496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histocompatibility antigens (HLA) in mental disorders].
    Miazgowska B
    Pol Tyg Lek; 1986 Jan; 41(4):125-6. PubMed ID: 3085074
    [No Abstract]   [Full Text] [Related]  

  • 23. The neurodevelopmental model of schizophrenia: update 2005.
    Rapoport JL; Addington AM; Frangou S; Psych MR
    Mol Psychiatry; 2005 May; 10(5):434-49. PubMed ID: 15700048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strong association of de novo copy number mutations with sporadic schizophrenia.
    Xu B; Roos JL; Levy S; van Rensburg EJ; Gogos JA; Karayiorgou M
    Nat Genet; 2008 Jul; 40(7):880-5. PubMed ID: 18511947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurodevelopmental theory of schizophrenia: evidence from studies of early onset cases.
    Kinros J; Reichenberg A; Frangou S
    Isr J Psychiatry Relat Sci; 2010; 47(2):110-7. PubMed ID: 20733253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Leister F; Yang S; Krivogorsky B; Alaedini A; Yolken R
    Biol Psychiatry; 2010 Jul; 68(1):100-4. PubMed ID: 20471632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset.
    Melas PA; Rogdaki M; Ösby U; Schalling M; Lavebratt C; Ekström TJ
    FASEB J; 2012 Jun; 26(6):2712-8. PubMed ID: 22426120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.
    Nimgaonkar VL; Prasad KM; Chowdari KV; Severance EG; Yolken RH
    Mol Psychiatry; 2017 Nov; 22(11):1554-1561. PubMed ID: 28761078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of schizophrenia--a review.
    Mäki P; Veijola J; Jones PB; Murray GK; Koponen H; Tienari P; Miettunen J; Tanskanen P; Wahlberg KE; Koskinen J; Lauronen E; Isohanni M
    Br Med Bull; 2005; 73-74():1-15. PubMed ID: 15947217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurological soft signs in early onset schizophrenia].
    Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
    Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-Wide Association Studies Suggest Limited Immune Gene Enrichment in Schizophrenia Compared to 5 Autoimmune Diseases.
    Pouget JG; Gonçalves VF; ; Spain SL; Finucane HK; Raychaudhuri S; Kennedy JL; Knight J
    Schizophr Bull; 2016 Sep; 42(5):1176-84. PubMed ID: 27242348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The histocompatibility system in schizophrenia].
    Gattaz WF; Beckmann H
    Arq Neuropsiquiatr; 1982 Sep; 40(3):223-9. PubMed ID: 6984326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in defining the biological causes of schizophrenia.
    Pickard B
    Expert Rev Mol Med; 2011 Jul; 13():e25. PubMed ID: 21794196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors for the development of schizophrenia].
    Löhrs L; Hasan A
    Fortschr Neurol Psychiatr; 2019 Feb; 87(2):133-143. PubMed ID: 30802921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of lymphotoxin-alpha (tumor necrosis factor-beta) in the development of schizophrenia.
    Pae CU
    Med Hypotheses; 2007; 68(6):1359-62. PubMed ID: 17140746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.
    Venkatasubramanian G; Debnath M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():301-11. PubMed ID: 23587629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a role for immune-to-brain communication in schizophrenia?
    Khandaker GM; Dantzer R
    Psychopharmacology (Berl); 2016 May; 233(9):1559-73. PubMed ID: 26037944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological studies of schizophrenia in Europe.
    Prilipko LL
    Schizophr Bull; 1986; 12(1):83-100. PubMed ID: 2421395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are some cases of psychosis caused by microbial agents? A review of the evidence.
    Yolken RH; Torrey EF
    Mol Psychiatry; 2008 May; 13(5):470-9. PubMed ID: 18268502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.